Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Neostigmine bromide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Neostigmine 15mg tablets
1002010M0AAAAAA
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | 23 |
|
Neostigmine 10mg/5ml oral solution
1002010M0AAAFAF
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 15mg/5ml oral solution
1002010M0AAAIAI
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 2.5mg/5ml oral solution
1002010M0AAAHAH
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 25mg/5ml oral solution
1002010M0AAAKAK
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 30mg/5ml oral solution
1002010M0AAANAN
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
|
Neostigmine 5mg/5ml oral solution
1002010M0AAAGAG
|
Neostigmine bromide | Neostigmine bromide | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.